No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NYXH Nyxoah SA
- 9.480
- -0.865-8.36%
Close May 1 16:00 ET
- 9.690
- +0.210+2.22%
Post 16:33 ET
271.91MMarket Cap-5752P/E (TTM)
10.540High9.010Low21.03KVolume10.210Open10.345Pre Close208.91KTurnover0.19%Turnover RatioLossP/E (Static)28.68MShares20.00052wk High2.60P/B104.05MFloat Cap4.00052wk Low--Dividend TTM10.98MShs Float37.000Historical High--Div YieldTTM14.79%Amplitude4.000Historical Low9.933Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Nyxoah SA Welcomes New Chief Medical Officer
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (NASDAQ:NYXH) ("Nyxoah" or the "Company"), a medical technology
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday's session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9
Enlivex Therapeutics, Nyxoah SA, China SXT Pharmaceuticals Among Healthcare Movers
CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday. Shares of CarMax, Inc. (NYSE:KMX) fell sharply in today's pre-market trading after the company r
Top Premarket Decliners
Aptevo Therapeutics (APVO) shares slumped 26% Thursday premarket, extending Wednesday's losses. United Homes Group (UHG) shares retreated 15% following a 2.1% drop in the previous session. SolarBank (
Comments
Watching for submission date
$Nyxoah SA(NYXH.US$ Nyxoah Says DREAM US Pivotal Study Meets Primary Endpoints
Moomoo 24/7· 11 mins ago
Olivier Taelman, Nyxoah's Chief Executive Officer, said, "We are finalizing the fourth and final module submission in the PMA application and I look forward to launching Genio in the U.S, pending FDA approval."
Moomoo 24/7· 11 mins ago
Olivier Taelman, Nyxoah's Chief Executive Officer, said, "We are finalizing the fourth and final module submission in the PMA application and I look forward to launching Genio in the U.S, pending FDA approval."
Update
$Nyxoah SA(NYXH.US$ Nyxoah Announces 2024 Strategic Priorities; Seeks To Complete Patient Follow Up In The DREAM U.S. Pivotal Study And Report Efficacy And Safety Data By Early April
Benzinga· 2 mins ago
Benzinga· 2 mins ago
ColumnsTop upgrades and downgrades on 4/21
Upgrades
• $Bank First(BFC.US$ : Piper Sandler Upgrades to Overweight From Neutral - PT $84 (from $76)
• $E2open Parent(ETWO.US$ : BofA Securities Upgrades to Buy from Neutral - PT $12
• $Harmonic(HLIT.US$ : Barclays Upgrades to Overweight from Equalweight - PT $11
• $MarketAxess(MKTX.US$ : Compass Point Upgrades to Neutral from Sell - PT $275 (from $300)
• $PBF Energy(PBF.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $30 (from $20)
• $Range Resources(RRC.US$ : Piper S...
• $Bank First(BFC.US$ : Piper Sandler Upgrades to Overweight From Neutral - PT $84 (from $76)
• $E2open Parent(ETWO.US$ : BofA Securities Upgrades to Buy from Neutral - PT $12
• $Harmonic(HLIT.US$ : Barclays Upgrades to Overweight from Equalweight - PT $11
• $MarketAxess(MKTX.US$ : Compass Point Upgrades to Neutral from Sell - PT $275 (from $300)
• $PBF Energy(PBF.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $30 (from $20)
• $Range Resources(RRC.US$ : Piper S...
9
ColumnsTop upgrades and downgrades on 4/6
Upgrades
• $Banc of California(BANC.US$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US$: Raymond James Upgrades to Outperform from Market Perfor...
• $Banc of California(BANC.US$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US$: Raymond James Upgrades to Outperform from Market Perfor...
7
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg